ArticleBMC cancer2025

Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer.

Zhaoda Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.